Botulinum toxin type B for gait freezing in Parkinson's disease

Freezing of Gait (FOG) can be a serious problem in Parkinson's disease (PD) and is usually refractory to medical treatment. Botulinum toxin (BTX) type A has been reported to relieve FOG in small open label studies. We performed a double-blind, placebo-controlled, parallel-group study using BTX-...

Full description

Saved in:

Bibliographic Details
Published in:	Medical science monitor Vol. 10; no. 7; p. CR282
Main Authors:	Fernandez, Hubert H, Lannon, Margaret C, Trieschmann, Martha E, Friedman, Joseph H
Format:	Journal Article
Language:	English
Published:	United States 01-07-2004
Subjects:	Aged Aged, 80 and over Anti-Dyskinesia Agents - administration & dosage Botulinum Toxins - administration & dosage Botulinum Toxins, Type A Double-Blind Method Gait Gait Disorders, Neurologic - drug therapy Gait Disorders, Neurologic - etiology Humans Injections, Intramuscular Middle Aged Muscle, Skeletal - drug effects Muscle, Skeletal - physiology Parkinson Disease - complications Parkinson Disease - drug therapy Severity of Illness Index Treatment Outcome Walking
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!